REPORTS

Let’s Pullulate and Expand Your Business

Postmenopausal Vaginal Atrophy Treatment Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019  |  189 PAGES  |  REPORT CODE: CMM208893
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Postmenopausal Vaginal Atrophy Treatment market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.0% during the forecast period.

This report presents the market size and development trends by detailing the Postmenopausal Vaginal Atrophy Treatment market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Postmenopausal Vaginal Atrophy Treatment market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Postmenopausal Vaginal Atrophy Treatment industry and will help you to build a panoramic view of the industrial development.

Postmenopausal Vaginal Atrophy Treatment Market, By Type:

  • Rings

  • Patches

  • Tablets

  • Creams

Postmenopausal Vaginal Atrophy Treatment Market, By Application:

  • Topical Estrogen

  • Systemic Estrogen

  • Others

Some of the leading players are as follows:

  • Vagisil

  • Salcura Topida

  • Balance Activ

  • Femarelle

  • K-Y

  • Clotrimazole

  • Replens MD

  • Canestest

  • Multi-Gyn

  • Vagisan

  • Canesten

  • Sylk

  • Canesbalance

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Postmenopausal Vaginal Atrophy Treatment Market: Technology Type Analysis

  • 4.1 Postmenopausal Vaginal Atrophy Treatment Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Postmenopausal Vaginal Atrophy Treatment Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Rings

    • 4.3.2 Patches

    • 4.3.3 Tablets

    • 4.3.4 Creams

5 Postmenopausal Vaginal Atrophy Treatment Market: Product Analysis

  • 5.1 Postmenopausal Vaginal Atrophy Treatment Product Market Share Analysis, 2018 & 2026

  • 5.2 Postmenopausal Vaginal Atrophy Treatment Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Postmenopausal Vaginal Atrophy Treatment Market: Application Analysis

  • 6.1 Postmenopausal Vaginal Atrophy Treatment Application Market Share Analysis, 2018 & 2026

  • 6.2 Postmenopausal Vaginal Atrophy Treatment Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Topical Estrogen

    • 6.3.2 Systemic Estrogen

    • 6.3.3 Others

7 Postmenopausal Vaginal Atrophy Treatment Market: Regional Analysis

  • 7.1 Postmenopausal Vaginal Atrophy Treatment Regional Market Share Analysis, 2018 & 2026

  • 7.2 Postmenopausal Vaginal Atrophy Treatment Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Vagisil

    • 9.1.1 Vagisil Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Salcura Topida

    • 9.2.1 Salcura Topida Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Balance Activ

    • 9.3.1 Balance Activ Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Femarelle

    • 9.4.1 Femarelle Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 K-Y

    • 9.5.1 K-Y Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Clotrimazole

    • 9.6.1 Clotrimazole Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Replens MD

    • 9.7.1 Replens MD Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Canestest

    • 9.8.1 Canestest Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Multi-Gyn

    • 9.9.1 Multi-Gyn Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Vagisan

    • 9.10.1 Vagisan Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Canesten

    • 9.11.1 Canesten Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Sylk

    • 9.12.1 Sylk Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Canesbalance

    • 9.13.1 Canesbalance Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 84 Figures and 141 Tables)

  • Figure Rings Postmenopausal Vaginal Atrophy Treatment market, 2015 - 2026 (USD Million)

  • Figure Patches Postmenopausal Vaginal Atrophy Treatment market, 2015 - 2026 (USD Million)

  • Figure Tablets Postmenopausal Vaginal Atrophy Treatment market, 2015 - 2026 (USD Million)

  • Figure Creams Postmenopausal Vaginal Atrophy Treatment market, 2015 - 2026 (USD Million)

  • Figure Topical Estrogen market, 2015 - 2026 (USD Million)

  • Figure Systemic Estrogen market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Postmenopausal Vaginal Atrophy Treatment market, by country, 2015 - 2026 (USD Million)

  • Table North America Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table North America Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table North America Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Canada Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Canada Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Europe Postmenopausal Vaginal Atrophy Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Europe Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Europe Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Europe Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Germany Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Germany Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table France Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table France Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Italy Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Italy Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Spain Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Spain Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table China Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table China Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Japan Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Japan Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table India Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table India Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Postmenopausal Vaginal Atrophy Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table MEA Postmenopausal Vaginal Atrophy Treatment market, by country, 2015 - 2026 (USD Million)

  • Table MEA Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table MEA Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table MEA Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Postmenopausal Vaginal Atrophy Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Postmenopausal Vaginal Atrophy Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Postmenopausal Vaginal Atrophy Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Vagisil Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Salcura Topida Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Balance Activ Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Femarelle Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table K-Y Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Clotrimazole Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Replens MD Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Canestest Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Multi-Gyn Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vagisan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Canesten Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sylk Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Canesbalance Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top